PADA-1 Update
Phase III PADA-1 Update: Palbociclib + Switching to Fulvestrant vs Continuing AI Therapy in ER+/HER2- MBC With Rising ESR1 Mutations by ctDNA Analysis

Released: June 14, 2023

Activity

Progress
1
Course Completed